Who owns Bioxcel Therapeutics Inc?
- Ticker: BTAI
- CUSIP Number: 09075p105
Tip: Access positions for across all investors
Analyze quarterly positions in Bioxcel Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioxcel Therapeutics stock
Who bought or sold Bioxcel Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.1M | $3.2M | -11% | Dec 2023 |
|
| Beacon Pointe Advisors | 302k | $890k | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 188k | $553k | 37% | Dec 2023 |
|
| Citadel Advisors | 152k | $448k | -2% | Dec 2023 |
|
| Bank of New York Mellon | 127k | $373k | -1% | Dec 2023 |
|
| Arete Wealth Advisors | 109k | $322k | 100% | Dec 2023 |
|
| Bank of America Corporation | 104k | $308k | 2% | Dec 2023 |
|
| Bank Of Montreal | 89k | $283k | 4% | Dec 2023 |
|
| Millennium Management | 88k | $260k | -40% | Dec 2023 |
|
| Wells Fargo & Company | 78k | $230k | 4% | Dec 2023 |
|
| Virtu Financial | 60k | $176k | 100% | Dec 2023 |
|
| Squarepoint Ops | 57k | $168k | 100% | Dec 2023 |
|
| Tocqueville Asset Management | 50k | $148k | 27% | Dec 2023 |
|
| UBS Group | 48k | $143k | -39% | Dec 2023 |
|
| D. E. Shaw & Co | 42k | $125k | 100% | Dec 2023 |
|
| Cambridge Investment Research Advisors | 38k | $112k | 100% | Dec 2023 |
|
| Hennion & Walsh Asset Management | 37k | $106k | 2% | Mar 2024 |
|
| Wellington Management Company | 37k | $109k | 0% | Dec 2023 |
|
| Davenport & Co | 35k | $104k | -42% | Dec 2023 |
|
| Jane Street | 31k | $92k | -78% | Dec 2023 |
|
| Alliancebernstein | 30k | $89k | -16% | Dec 2023 |
|
| Rhumbline Advisers | 29k | $86k | 6% | Dec 2023 |
|
| Barclays | 28k | $82k | 264% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 23k | $69k | -69% | Dec 2023 |
|
| Creative Planning | 20k | $60k | -5% | Dec 2023 |
|
| Goldman Sachs Group | 19k | $57k | -86% | Dec 2023 |
|
| Raymond James & Associates | 19k | $56k | 13% | Dec 2023 |
|
| Us Bancorp | 18k | $53k | 0% | Dec 2023 |
|
| Capital Investment Advisory Services | 18k | $53k | -1% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 18k | $52k | 612% | Dec 2023 |
|
| SeaCrest Wealth Management | 17k | $49k | -5% | Mar 2024 |
|
| Jpmorgan Chase & Co | 13k | $38k | -1% | Dec 2023 |
|
| Branch Banking & Trust Company | 11k | $32k | 100% | Dec 2023 |
|
| Apollon Wealth Management | 11k | $31k | 100% | Dec 2023 |
|
| American International | 10k | $30k | 0% | Dec 2023 |
|
| Zurcher Kantonalbank | 7.9k | $23k | -31% | Dec 2023 |
|
| Royal Bank of Canada | 6.7k | $18k | 118% | Dec 2023 |
|
| AllSquare Wealth Management | 4.5k | $13k | 0% | Dec 2023 |
|
| Cutler | 3.1k | $9.0k | -70% | Dec 2023 |
|
| Legal & General Group | 3.0k | $8.9k | -77% | Dec 2023 |
|
| Citigroup | 2.9k | $8.4k | -88% | Dec 2023 |
|
| Amalgamated Bank | 2.8k | $8.0k | -7% | Dec 2023 |
|
| Washington Trust Advisors | 2.6k | $7.6k | 106% | Dec 2023 |
|
| National Bank Of Canada /fi/ | 1.9k | $5.5k | 60% | Dec 2023 |
|
| Summit Investment Advisors | 1.4k | $4.0k | 0% | Dec 2023 |
|
| Armstrong Advisory Group | 1.0k | $3.0k | 0% | Mar 2024 |
|
| Pnc Financial Services | 937.00 | $2.8k | 100% | Dec 2023 |
|
| Toth Financial Advisory Corporation | 500.00 | $1.4k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 430.00 | $1.3k | 43% | Dec 2023 |
|
| Massmutual Trust | 297.00 | $837.985500 | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 273.00 | $999.999000 | -10% | Dec 2023 |
|
| Russell Investments | 88.00 | $259.996000 | 100% | Dec 2023 |
|
| Capital Advisors | 33.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Bioxcel Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Sep 2023 | 433k | $1.1M |
| Two Sigma Advisers | Sep 2023 | 74k | $187k |
| Hrt Financial | Sep 2023 | 72k | $182k |
| Knoll Capital Management | Sep 2023 | 60k | $152k |
| Swiss National Bank | Sep 2023 | 44k | $112k |
| Marshall Wace | Sep 2023 | 28k | $71k |
| Credit Suisse | Sep 2023 | 22k | $55k |
| Balyasny Asset Management | Sep 2023 | 21k | $53k |
| Point72 Middle East FZE | Sep 2023 | 16k | $40k |
| Simplex Trading | Sep 2023 | 8.1k | $20k |
| Virtus ETF Advisers | Sep 2023 | 4.6k | $12k |
| Point72 Asset Management | Sep 2023 | 2.7k | $6.8k |
| Fifth Third Bancorp | Sep 2023 | 1.0k | $2.5k |
| NISA Investment Advisors | Sep 2023 | 97.00 | $245.002600 |